Medical research

New approach to slowing aggressive leukemia

A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory ...

Medications

AI-based analysis on drug-drug interactions involving Paxlovid

Professor Sang Yup Lee's research team in KAIST's Department of Biochemical Engineering has developed an advanced AI-based drug interaction prediction technology that analyzed the interaction between Paxlovid ingredients ...

Medical research

Tracking down leaks in the blood-brain barrier

In epilepsy research, it has long been assumed that a leaky blood-brain barrier is a cause of inflammation in the brain. Using a novel method, researchers from Bonn University Hospital (UKB) and the University of Bonn have ...

Cardiology

Developing a digital marker for coronary artery disease

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease ...

Medical research

Microparticles could help prevent vitamin A deficiency

Vitamin A deficiency is the world's leading cause of blindness, and in severe cases, it can be fatal. About one-third of the global population of preschool-aged children suffer from this vitamin deficiency, which is most ...

Oncology & Cancer

Protein spheres protect the genome of cancer cells

MYC genes and their proteins play a central role in the emergence and development of almost all cancers. They drive the uncontrolled growth and altered metabolism of tumor cells. And they help tumors hide from the immune ...

page 3 from 40